Mao L, Wang J Q
Division of Pharmacology, School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri 64108, USA.
Synapse. 2001 Jan;39(1):82-94. doi: 10.1002/1098-2396(20010101)39:1<82::AID-SYN11>3.0.CO;2-B.
Group I metabotropic glutamate receptors (mGluRs) are positively coupled to phosphoinositide hydrolysis through G-proteins and are densely expressed in the medium-sized spiny neurons of striatum. Activation of this group of mGluRs in the striatum produces long-lasting stimulation of behavioral activity. In this study, the role of group I mGluRs in the modulation of neuropeptide mRNA expression in striatal neurons was investigated using a Group I-selective agonist, 3,5-dihydroxyphenylglycine (DHPG) in chronically cannulated rats. Unilateral injections of DHPG into the dorsal striatum (caudoputamen) at behaviorally active doses of 20, 40, and 80 nmol elevated basal levels of preprodynorphin (PPD), substance P (SP), and preproenkephalin (PPE) mRNAs in the injected dorsal striatum as revealed by quantitative in situ hybridization. The elevation of all three mRNAs was dose-dependent and the responsiveness of opioid peptide mRNAs (PPD and PPE) to acute injection of DHPG at each dose surveyed was greater than that of SP mRNA. Induction of the mRNAs was delayed and prolonged as increases in hybridization signal became evident at 2 (SP and PPE) or 3 (PPD) h, reached a peak between 3 and 6 h, and returned to normal levels 24 h after DHPG injection. Coadministration of a Group I-selective antagonist, n-phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-carbo xamide (PHCCC, 10 nmol), with DHPG markedly attenuated DHPG-stimulated PPD, PPE, and, to a lesser extent, SP expression. Administration of PHCCC alone had no significant effect on basal levels of three mRNA expression in the striatum. This study provides a detailed description of the dose- and time-related alterations in striatonigral PPD/SP and striatopallidal PPE mRNA expression in response to a single injection of the Group I agonist DHPG. Data obtained demonstrate a facilitatory, dynamic regulation of constitutive expression of PPD, SP, and PPE mRNAs by local enhancement of glutamatergic tone on DHPG- and PHCCC-sensitive Group I mGluRs.
I 型代谢型谷氨酸受体(mGluRs)通过 G 蛋白与磷酸肌醇水解呈正偶联,且在纹状体的中型棘状神经元中密集表达。纹状体内这一组 mGluRs 的激活会对行为活动产生持久的刺激。在本研究中,使用 I 型选择性激动剂 3,5 - 二羟基苯甘氨酸(DHPG),对长期插管大鼠纹状体神经元中 I 型 mGluRs 在神经肽 mRNA 表达调节中的作用进行了研究。通过定量原位杂交发现,以 20、40 和 80 nmol 的行为活性剂量将 DHPG 单侧注射到背侧纹状体(尾壳核)中,可提高注射侧背侧纹状体中前强啡肽原(PPD)、P 物质(SP)和前脑啡肽原(PPE)mRNA 的基础水平。所有三种 mRNA 的升高均呈剂量依赖性,并且在所检测的每个剂量下,阿片肽 mRNA(PPD 和 PPE)对急性注射 DHPG 的反应性均大于 SP mRNA。mRNA 的诱导延迟且持续时间长,因为杂交信号在 2 小时(SP 和 PPE)或 3 小时(PPD)时开始明显增加,在 3 至 6 小时达到峰值,并在 DHPG 注射后 24 小时恢复到正常水平。将 I 型选择性拮抗剂 n - 苯基 - 7 - (羟基亚氨基)环丙[b]色烯 - 1a - 羧酸酰胺(PHCCC,10 nmol)与 DHPG 共同给药,可显著减弱 DHPG 刺激的 PPD、PPE 以及程度较轻的 SP 表达。单独给予 PHCCC 对纹状体中三种 mRNA 表达的基础水平无显著影响。本研究详细描述了单次注射 I 型激动剂 DHPG 后,纹状体黑质 PPD/SP 和纹状体苍白球 PPE mRNA 表达的剂量和时间相关变化。所获得的数据表明,通过对 DHPG 和 PHCCC 敏感的 I 型 mGluRs 上谷氨酸能张力的局部增强,对 PPD、SP 和 PPE mRNA 的组成性表达进行促进性的动态调节。